Mirion Technologies(NYSE) MIR

Mirion Technologies, Inc. helps people use radiation safely. Its tools protect medical staff and patients in hospitals. The company also builds sensors for nuclear power plants.

Tools for a Radioactive World

• Nuclear & Safety: Equipment for monitoring radiation in power plants, labs, and defense environments; accounted for 69.8% of revenue for the three-month period ended June 30, 2026.
• Medical Quality Assurance: Tools for verifying the accuracy of diagnostic imaging and radiation therapy machines; part of the Medical segment representing 30.2% of revenue for the three-month period ended June 30, 2026.
• Dosimetry Solutions: Wearable badges and software that track the total amount of radiation medical professionals are exposed to over time.
• Radionuclide Therapy: Specialized shielding, handling equipment, and furniture used for nuclear medicine treatments.
• Nuclear Power Products: Sensors and control systems used throughout the full 40 to 100 year operating life cycle of nuclear reactors.

Building a Bigger Footprint

• Acquired Paragon Energy Solutions on Dec. 1, 2025, to provide highly engineered products for the U.S. nuclear market and small modular reactors.
• Purchased Certrec on July 31, 2025, to add digital regulatory compliance and integration solutions for energy customers.
• Refinanced existing term loans in June 2025 to reduce total debt balances and lower interest expense.
• Established a new artificial intelligence function in 2026 to improve internal technology infrastructure and customer services.

Global Reach and Installed Base

Mirion maintains an international footprint with operations in countries such as the United States, France, and China. Its sensors are installed at most active nuclear reactors globally, supporting a cycle of recurring replacement and service revenue.

Tracking the Money

• Revenue was $266.8 million for the three-month period ended June 30, 2026, compared with $222.9 million for the same period in 2025.
• Net income reached $8.1 million for the three months ended June 30, 2026.
• Order backlog was $1,138.6 million as of June 30, 2026, up from $1,104.3 million on Dec. 31, 2025.
• Net cash provided by operating activities was $77.4 million for the six months ended June 30, 2026, an increase of $29.4 million year over year.
• Total cash, cash equivalents, and restricted cash stood at $421.6 million as of June 30, 2026.

Bottom Line

Mirion has evolved from a monitoring specialist into a diversified provider of radiation safety and medical diagnostic technologies. Its presence in global energy and healthcare markets supports long-term stability through essential safety and compliance services.